NewsBenzingaGSK: el BPA ajustado del tercer trimestre de $1.47 supera la estimación de $1.40; las ventas de $11.948B superan la estimación de $11.800B GSK: el BPA ajustado del tercer trimestre de $1.47 supera la estimación de $1.40; las ventas de $11.948B superan la estimación de $11.800B Benzinga 2026.10.28 07:21 (GMT+0) Open on Benzinga Other news Swoosh and a Miss: Nike Investor Day Leaves Wall Street Cold-Footed Wall Street Says the AI Trade Is Over — ETF Investors Aren’t Acting Like It Citigroup Maintains Neutral on Westlake, Lowers Price Target to $65 Citigroup Maintains Neutral on LyondellBasell Industries, Lowers Price Target to $66 Caterpillar's 'Best-In-Class' Construction Business Is Getting Overlooked, Analyst Says How to Play NKE Stock as Nike Risks Becoming a Forever Turnaround Story